Liquid Bowel Prep Composition With pH-Stable Magnesium-Citrate Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmaceutical powders containing sodium picosulfate, magnesium oxide, and citric acid face stability issues due to chemical reactions that lead to precipitation and pH instability, affecting efficacy and patient comfort.
Innovation Solution
A stable pharmaceutical liquid composition is formulated with sodium picosulfate, magnesium oxide, citric acid, and malic acid, maintaining a pH range of 4.1 to 5.4, and optionally including excipients like pH adjusters and sweeteners to enhance stability and patient compliance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If the medicine is stored as a liquid composition with citric acid and magnesium oxide, then patient convenience is improved, but chemical stability deteriorates due to reaction between citric acid and magnesium oxide forming magnesium citrate that precipitates over time
Solution Approach 1:
Sodium hydroxide is introduced as an intermediary substance to neutralize citric acid and form sodium citrate, which serves as a stable mediator that prevents direct reaction between citric acid and magnesium oxide. This intermediary approach resolves the contradiction by enabling liquid storage convenience while maintaining chemical stability through the buffering action of sodium citrate.
Solution Approach 2:
The pH parameter is adjusted and maintained within a specific range (4.0-6.0) to prevent precipitation of magnesium citrate. By controlling this critical parameter, the formulation achieves both liquid storage stability and prevention of chemical reactions between ingredients, resolving the contradiction between convenience and stability.
2Stability of the object's composition
If the pH is kept low to reduce precipitation, then physical stability is improved, but chemical stability deteriorates as sodium picosulfate becomes unstable
Solution Approach 1:
The pH parameter is optimized to a specific range (4.0-6.0) that simultaneously maintains physical stability by preventing magnesium citrate precipitation and chemical stability by preserving sodium picosulfate integrity. This precise parameter control resolves the contradiction between physical and chemical stability requirements.
Solution Approach 2:
The formulation uses a composite system combining sodium picosulfate, magnesium oxide, citric acid, sodium hydroxide, and sodium citrate that work together synergistically. This composite approach allows the system to maintain both physical stability (through controlled precipitation prevention) and chemical stability (through pH buffering and component compatibility).
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The liquid composition maintains chemical stability for 24 months with minimal precipitation and ensures effective colon cleansing, improving patient convenience and compliance.
Implementation Method 1
citric acid and magnesium oxide that are chief ingredients may react with each other to become magnesium citrate
Implementation Method 2
The liquid composition maintains a pH range of 4.1 to 5.4, and optionally including excipients like pH adjusters
Implementation Method 3
optionally including excipients like pH adjusters
Data Source
AI summary
Described are oral, liquid pharmaceutical compositions that include sodium picosulfate, magnesium oxide, citric acid, and malic acid, and methods of making and using such compositions.